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Surgery versus Physical Therapy for a Meniscal Tear
and Osteoarthritis
Jeffrey N. Katz, M.D., Robert H. Brophy, M.D., Christine E. Chaisson, M.P.H., Leigh de Chaves, P.T., O.C.S.,
Brian J. Cole, M.D., M.B.A., Diane L. Dahm, M.D., Laurel A. Donnell-Fink, M.P.H., Ali Guermazi, M.D., Ph.D.,
Amanda K. Haas, M.A., Morgan H. Jones, M.D., M.P.H., Bruce A. Levy, M.D., Lisa A. Mandl, M.D., M.P.H.,
Scott D. Martin, M.D., Robert G. Marx, M.D., Anthony Miniaci, M.D., Matthew J. Matava, M.D.,
Joseph Palmisano, M.P.H., Emily K. Reinke, Ph.D., Brian E. Richardson, P.T., M.S., S.C.S., C.S.C.S.,
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John Wright, M.D., Rick W. Wright, M.D., and Elena Losina, Ph.D.

A bs t r ac t
Background

Whether arthroscopic partial meniscectomy for symptomatic patients with a meniscal tear and knee osteoarthritis results in better functional outcomes than nonoperative therapy is uncertain.
Methods

We conducted a multicenter, randomized, controlled trial involving symptomatic patients 45 years of age or older with a meniscal tear and evidence of mild-to-moderate
osteoarthritis on imaging. We randomly assigned 351 patients to surgery and postoperative physical therapy or to a standardized physical-therapy regimen (with the option
to cross over to surgery at the discretion of the patient and surgeon). The patients were
evaluated at 6 and 12 months. The primary outcome was the difference between the
groups with respect to the change in the Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) physical-function score (ranging from 0 to 100, with
higher scores indicating more severe symptoms) 6 months after randomization.
Results

In the intention-to-treat analysis, the mean improvement in the WOMAC score after
6 months was 20.9 points (95% confidence interval [CI], 17.9 to 23.9) in the surgical
group and 18.5 (95% CI, 15.6 to 21.5) in the physical-therapy group (mean difference,
2.4 points; 95% CI, −1.8 to 6.5). At 6 months, 51 active participants in the study who
were assigned to physical therapy alone (30%) had undergone surgery, and 9 patients
assigned to surgery (6%) had not undergone surgery. The results at 12 months were
similar to those at 6 months. The frequency of adverse events did not differ significantly between the groups.
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Conclusions

In the intention-to-treat analysis, we did not find significant differences between the
study groups in functional improvement 6 months after randomization; however,
30% of the patients who were assigned to physical therapy alone underwent surgery
within 6 months. (Funded by the National Institute of Arthritis and Musculoskeletal
and Skin Diseases; METEOR ClinicalTrials.gov number, NCT00597012.)
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ymptomatic, radiographically confirmed osteoarthritis of the knee affects
more than 9 million people in the United
States.1 Meniscal tears are also highly prevalent,
with imaging evidence of a meniscal tear observed in 35% of persons older than 50 years of
age; two thirds of these tears are asymptomatic.2
Meniscal damage is especially prevalent among
persons with osteoarthritis3,4 and is frequently
treated surgically with arthroscopic partial meniscectomy. This procedure, in which the surgeon
trims the torn meniscus back to a stable rim, is
performed for a range of indications in more than
465,000 persons annually in the United States.5
The high prevalence of meniscal tears in patients with osteoarthritis of the knee and the
observation that these lesions are often asymptomatic challenge the ability of clinicians to determine whether symptoms are caused by the
tear, osteoarthritis, or both. Clinicians who suspect that the tear is symptomatic may refer the
patient to a surgeon for arthroscopic partial meniscectomy. The role of arthroscopic surgery in
patients with osteoarthritis has been studied in
two randomized, controlled trials over the past
decade. One trial6 compared arthroscopic débridement and lavage with a sham surgical procedure, and the other7 compared arthroscopic
débridement with a nonoperative regimen. Neither trial showed a statistically significant or
clinically important difference between the arthroscopic and nonoperative groups with respect
to functional improvement or pain relief over a
period of 24 months.6,7
These landmark trials established that arthroscopic treatment was not superior to the
other interventions in the treatment of knee osteoarthritis, but they did not focus on management of a symptomatic meniscal tear, which is a
frequent indication for knee arthroscopy in patients with osteoarthritis of the knee. The efficacy of arthroscopic partial meniscectomy in
symptomatic patients with a meniscal tear and
osteoarthritis has been evaluated, to our knowledge, in only one randomized, controlled trial,
which was a single-center study involving 90 patients.8,9 This study did not show a significant
difference in pain relief or functional status between arthroscopic partial meniscectomy plus a
physical-therapy regimen and physical therapy
alone. Given the frequency and cost of arthroscopic partial meniscectomy and the paucity of data,
1676

n engl j med 368;18

of

m e dic i n e

we designed the Meniscal Tear in Osteoarthritis
Research (METEOR) trial to assess the efficacy of
arthroscopic partial meniscectomy as compared
with a standardized physical-therapy regimen for
symptomatic patients with a meniscal tear and
concomitant mild-to-moderate osteoarthritis.

Me thods
Study Design and Oversight

This randomized, controlled trial was conducted
in seven U.S. tertiary referral centers. Details of
the trial design and conduct have been published
elsewhere.10 The study was approved by the Partners HealthCare Human Research Committee and
overseen by a data and safety monitoring board
assembled by the National Institute of Arthritis
and Musculoskeletal and Skin Diseases. There
was no commercial sponsorship of this trial. The
first and last authors vouch for the accuracy of
the reported data and analyses and the adherence
of the study to the protocol; the protocol and the
statistical analysis plan are available with the full
text of this article at NEJM.org.
Enrollment and Randomization

We enrolled symptomatic patients 45 years of age
or older with a meniscal tear as well as osteoarthritis detected on magnetic resonance imaging
(MRI) or radiography. Since osteoarthritis-defining features can be seen on MRI before changes
consistent with osteoarthritis can be detected on
radiography, patients with normal findings on
radiography and cartilage defects on MRI were
eligible. We required that patients have at least one
symptom that was consistent with a meniscal
tear11 that had persisted for at least 1 month despite pharmacologic treatment, physical therapy,
or limitation of activity. Detailed entry and exclusion criteria (including specific symptoms that were
consistent with a meniscal tear) are provided in
Table 1 in the Supplementary Appendix, available
at NEJM.org.
Research coordinators at each center reviewed
outpatient schedules to identify patients who were
potentially eligible to participate in the study.
The surgeon assessed eligibility criteria and referred eligible patients to the research coordinator, who introduced the study using a standardized script. Surgeons and coordinators told patients
randomly assigned to physical therapy alone that
they would have the opportunity to cross over to
nejm.org
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arthroscopic partial meniscectomy over time if
the patient and surgeon thought it was clinically
indicated. Patients who wished to participate provided written informed consent and completed a
baseline questionnaire.
Patients were then randomly assigned in a 1:1
ratio to a treatment group with the use of a secure
program on the trial website. Randomization was
conducted in blocks of varying size within each
site, stratified according to sex and the extent of
osteoarthritis on baseline radiography (either
Kellgren–Lawrence grade 0 to 2 [no joint-space
narrowing] or Kellgren–Lawrence grade 3 [≤50%
joint-space narrowing]).
After randomization, the patient was informed
about the treatment assignment; the surgeon was
informed as part of the surgical booking process. Treatment was generally scheduled within
2 to 4 weeks after randomization.
Interventions

tocol was based on literature supporting the effectiveness of land-based, individualized physical
therapy with progressive home exercise for patients with knee osteoarthritis.10,12,13 The threestage structured program was designed to address inflammation, range of motion, concentric
and eccentric muscle strength, muscle-length restrictions, aerobic conditioning (e.g., with the
use of a bicycle, elliptical machine, or treadmill),
functional mobility, and proprioception and balance. Details of the physical-therapy program are
described in Table 2 in the Supplementary Appendix. Criteria for advancing from stage I to II
and from stage II to III included the level of selfreported pain, observed strength, range of knee
motion, knee effusion, and functional mobility.
At each stage, it was recommended that the patient attend physical-therapy sessions once or
twice weekly and perform exercises at home. Patients progressed at their own pace; the duration
of participation varied depending on the pace of
improvement. Generally, the program lasted about
6 weeks.
In both the arthroscopic-partial-meniscectomy
and physical-therapy groups, patients were permitted to receive acetaminophen and nonsteroidal
antiinflammatory agents as needed. Intraarticular
injections of glucocorticoids were permitted over
the course of the trial.

Teams of surgeon investigators met in person on
two occasions and regularly by telephone conference call throughout enrollment, as did teams of
physical therapists. These teams developed standardized surgical and physical-therapy interventions that were implemented in all study centers.
Standardization was developed further in telephone
conference calls and meetings with the use of
case examples. All surgeons were fellowshiptrained and performed at least 50 arthroscopic Outcomes
partial meniscectomies annually. Most of the The primary outcome was the difference between
therapists were board-certified.
the study groups with respect to the change in the
score on the physical-function scale of the WestArthroscopic Partial Meniscectomy
ern Ontario and McMaster Universities OsteoarThe protocol called for surgeons to perform an thritis Index (WOMAC)14 from baseline to 6 months
arthroscopic partial meniscectomy by trimming after randomization. WOMAC scores range from
the damaged meniscus back to a stable rim. Sur- 0 to 100, with higher scores indicating worse physgeons removed loose fragments of cartilage and ical function. The original statistical-analysis plan
bone, but this procedure did not involve penetra- referred to the primary outcome as the WOMAC
tion of the subchondral bone. Preoperative anti- function score at 6 months, with adjustment for
biotics were used routinely. Postoperatively, pa- the baseline score. However, since the change in
tients were allowed to bear weight as they were the WOMAC physical-function score is a stanable. Bracing was not used. Patients were referred dard outcome in assessing interventions for knee
to a physical therapist for a postoperative stan- osteoarthritis and is more easily interpreted than
dardized physical-therapy program with the use the raw score at 6 months adjusted for the baseof the same protocol as that used in the physical- line score, we revised the primary outcome before
therapy group, described below.
analyzing the trial data. We specified 6 months as
the time for assessment of the primary outcome
Physical Therapy
because the clinical response to treatment is apparThe physical-therapy protocol was developed by a ent by this time. We added a 12-month assessment
team of experienced physical therapists. The pro- to determine whether the response was stable.
n engl j med 368;18
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14,430 Patients were assessed
for eligibility
14,079 Did not undergo randomization
1,092 Were not screened by
physician
12,008 Did not meet inclusion
criteria
3690 Underwent previous
surgery
2691 Did not have MRI
2198 Had patellofemoral
disorder
1816 Had grade 4 on
Kellgren–Lawrence
scale
1613 Had other reasons
195 Were eligible, but were
not referred
784 Were eligible, but declined
to participate
283 Had preference for
APM
166 Had preference for PT
335 Had other reason
351 Underwent randomization

174 Were assigned to APM

177 Were assigned to PT

13 Did not complete study through
6 mo
1 Died
3 Underwent TKR
7 Withdrew
2 Were ineligible
161 Were evaluated in 6-mo follow-up
9 Did not undergo APM

8 Did not complete study through
6 mo
1 Died
1 Underwent TKR
4 Withdrew
2 Were lost to follow-up
169 Were evaluated in 6-mo follow-up
51 Crossed over and underwent APM

18 Did not complete study through
12 mo
1 Died
5 Underwent TKR
9 Withdrew
2 Were ineligible
1 Was lost to follow-up
156 Were evaluated in 12-mo follow-up
9 Did not undergo APM

13 Did not complete study through
12 mo
1 Died
3 Underwent TKR
7 Withdrew
2 Were lost to follow-up
164 Were evaluated in 12-mo follow-up
59 Crossed over and underwent
APM

of
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ies involving patients with a meniscal tear,15,16
and the score on the physical-activity scale of the
Medical Outcomes Study 36-Item Short-Form
Health Survey (SF-36). Scores on both scales range
from 0 to 100, with higher KOOS scores indicating more severe pain and higher SF-36 scores
indicating greater physical activity.17 We also considered a binary outcome that was defined as
improvement in the WOMAC physical-function
score of at least 8 points (a clinically relevant
difference specified a priori10,18,19) without crossover to the other study group.
Assessments

Questionnaires were administered at baseline and
3, 6, and 12 months after randomization. The
primary outcome was assessed at 6 months, with
the 3-month and 12-month assessments used to
capture the trajectory and stability of the treatment response. Site coordinators contacted the
participants by telephone every other week for
the first 3 months after randomization and quarterly thereafter to ascertain adverse events and
compliance with physical therapy. Surgeons, patients, and research staff were aware of the treatment assignments.
Radiographs of the weight-bearing knee were
assessed at each study site by the participating
surgeon on the basis of the Kellgren–Lawrence
grade20 and were then reassessed centrally (also on
the basis of the Kellgren–Lawrence grade)21 by a
musculoskeletal radiologist. The concordance between these readings was 71.8%. Readings performed at the clinical site were used for assessing eligibility and randomization strata, whereas
central readings were used in the analysis. Analyses performed with readings at the clinical site
did not materially differ from those performed
with central readings.
Statistical Analysis

The primary analysis was implemented with an
analysis of covariance with changes in the
WOMAC physical-function score from baseline to
6 months as the dependent variable, treatment as
Figure 1. Trial Enrollment and Follow-up.
the independent variable of interest, and study
Revised
AUTHOR:
Katz
APM denotes
arthroscopic
partial meniscectomy, MRI
magnetic resonance
site as a covariate. Other covariates, such as age,
imaging, PT physical therapy, and TKR total knee replacement.
FIGURE: 1 of 2
sex, and baseline Kellgren–Lawrence grade, were
SIZE
ARTIST: ts
balanced across groups and were therefore not
4 col pain score on included in the analysis. The primary analysis
Secondary
the
Combo outcomes
4-C
H/Twere 22p3
TYPE: Line
the Knee
Injury and Osteoarthritis Outcome Scale used a modified intention-to-treat approach in
AUTHOR, PLEASE NOTE:
Figure
has beenwhich
redrawnhas
and type
hasused
been reset.
(KOOS),
been
frequently in stud- which patients who did not withdraw from the
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study were evaluated in the group to which they
were randomly assigned. We performed three secondary analyses: an analogous intention-to-treat
analysis of covariance with the use of either the
KOOS pain score or the SF-36 physical-activity
score as the dependent variables and a logistic
regression, with adjustment for the study site,
which used the binary outcome defined above. We
prespecified one subgroup analysis based on the
baseline radiographic grade (Kellgren–Lawrence
grade 0 to 2 vs. Kellgren–Lawrence grade 3).10,22
Additional analyses with adjustment for uncertainty due to missing data are described in the
Supplementary Appendix.23
We powered the study to detect a 10-point difference in the WOMAC physical-function score
between the arthroscopic-partial-meniscectomy
and physical-therapy groups. This was the difference we noted in observational pilot data, and
it is close to the minimal clinically important
difference in the WOMAC physical-function
score among patients with osteoarthritis.18,19 On
the basis of a type I error rate of 5% and a
power of 80%, and taking into account potential
losses to follow-up and crossovers from the assigned group to the other group before the assessment of the primary outcome, we set the
target sample size at 340 patients.

R e sult s
Characteristics of the Study Population

From June 2008 through August 2011, a total of
14,430 patients were screened in seven study centers, of whom 1330 (9.2%) were eligible. Of these
patients, 351 (26.4%) were enrolled and randomly
assigned to a treatment group (Fig. 1). The two
groups were similar with respect to age, sex, race
or ethnic group, baseline Kellgren–Lawrence grade
of radiographic severity, and baseline WOMAC
physical-function score (Table 1).
Outcomes

In the intention-to-treat analysis that was adjusted
for the study site, the mean improvement in the
WOMAC physical-function score from baseline
to 6 months was 20.9 points in the group randomly assigned to arthroscopic partial meniscectomy, as compared with 18.5 points in the
physical-therapy group (between-group difference, 2.4 points; 95% confidence interval [CI],
−1.8 to 6.5) (Table 2 and Fig. 2A). Results of the
n engl j med 368;18

Table 1. Baseline Characteristics of the Patients.*

Characteristic
Mean age — yr

Arthroscopic Partial
Meniscectomy
Physical Therapy
(N = 161)
(N = 169)
59.0±7.9

57.8±6.8

Male

71 (44.1)

72 (42.6)

Female

90 (55.9)

97 (57.4)

White

138 (85.7)

142 (84.0)

Black

15 (9.3)

17 (10.1)

Hispanic

2 (1.2)

5 (3.0)

Other

6 (3.7)

5 (3.0)

70 (43.5)

68 (40.2)

Sex — no. (%)

Race or ethnic group — no. (%)†

Index knee — no. (%)
Right

91 (56.5)

101 (59.8)

Mean body-mass index

Left

30.0±6.1

30.0±6.1

WOMAC physical-function score‡

37.1±17.9

37.5±18.3

KOOS pain score§

46.0±15.5

47.2±16.4

Mental Health Index 5 score¶

74.8±12.9

74.0±13.9

SF-36 physical-activity score‖

44.3±23.7

43.3±23.3

0

34 (21.1)

36 (21.3)

1

26 (16.1)

35 (20.7)

2

37 (23.0)

39 (23.1)

3

45 (28.0)

39 (23.1)

Kellgren–Lawrence grade — no. (%)**

* Plus–minus values are means ±SD. There were no significant differences between the groups. Percentages may not sum to 100 because of rounding.
The body-mass index is the weight in kilograms divided by the square of the
height in meters.
† Race and ethnic group were self-reported.
‡ Scores on the physical-function subscale of the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC) range from 0 to 100,
with higher scores indicating more limitation of physical function.
§ Scores on the pain scale of the Knee Injury and Osteoarthritis Outcome
Scale (KOOS) range from 0 to 100, with higher scores indicating more pain.
¶ Scores on the Mental Health Index 5 range from 0 to 100, with higher scores
indicating better mental health.
‖ Scores on the physical-activity scale of the Medical Outcomes Study 36-Item
Short-Form Health Survey (SF-36) range from 0 to 100, with higher scores
indicating greater physical activity.
** A Kellgren–Lawrence grade of 0 (no osteophytes or joint-space narrowing)
indicates no osteoarthritis, a grade of 1 (questionable osteophyte) indicates
possible osteoarthritis; a grade of 2 (definite osteophyte, no joint-space narrowing) indicates mild osteoarthritis, a grade of 3 (≤50% joint-space narrowing) indicates moderate osteoarthritis, and a grade of 4 (>50% jointspace narrowing) indicates severe osteoarthritis. In 11.8% of patients,
Kellgren–Lawrence grades were not assessed centrally.

analysis (as originally specified) of the 6-month
WOMAC physical-function score, adjusted for the
baseline score, likewise did not show a clinically
important or statistically significant difference
nejm.org
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19.1 (16.4 to 21.9)
69.0 (64.6 to 73.4)

SF-36 physical-activity score

14.5 (12.0 to 16.9)
71.4 (67.0 to 75.7)

19.3 (16.6 to 22.0)

23.5 (20.5 to 26.5)
25.0 (20.9 to 29.1)

26.8 (23.7 to 30.0)

22.8 (19.8 to 25.8)
28.1 (24.0 to 32.1)

27.3 (24.1 to 30.4)

−3.0 (−8.8 to 2.7)

−0.4 (−4.8 to 4.0)

0.7 (−3.5 to 4.9)

1.1 (−4.4 to 6.6)

2.9 (−1.2 to 7.0)

2.4 (−1.8 to 6.5)†

* Between-group differences may not equal the differences in change from baseline between the partial-meniscectomy and physical-therapy groups because of rounding. CI denotes confidence interval.
† This between-group difference was the primary outcome.
‡ Treatment success indicates an improvement in the WOMAC physical-function score of 8 points or more, with no crossover.
§ Eight patients in the partial-meniscectomy group crossed over to surgery within 6 months, and 1 crossed over after 6 months.

13.7 (11.2 to 16.2)

WOMAC physical-function score

KOOS pain score

13 (8)

51/82 (62)

23.1 (19.2 to 27.0)

21.3 (18.4 to 24.2)

18.5 (15.6 to 21.5)

Physical Therapy

of

12 Months — mean (95% CI)

13 (8)

8/40 (20)

Crossover within 6 mo — no./total no. (%)§

31/82 (38)

82 (49)

74 (44)

24.2 (20.3 to 28.0)

24.2 (21.3 to 27.1)

20.9 (17.9 to 23.9)

Arthroscopic Partial
Meniscectomy

Improvement from Baseline

Between-Group
Difference in
Improvement
from Baseline

n e w e ng l a n d j o u r na l

Data missing — no. (%)

32/40 (80)

40 (25)

Treatment failure — no. (%)

WOMAC physical-function score improvement <8 points
and no crossover — no./total no. (%)

108 (67)

Treatment success — no. (%)‡

25.2 (22.4 to 28.0)
66.1 (62.1 to 70.1)

21.1 (18.3 to 23.9)
69.2 (65.2 to 73.2)

KOOS pain score — mean (95% CI)

SF-36 physical-activity score — mean (95% CI)

Physical Therapy
(N = 169)

19.0 (16.3 to 21.7)

Arthroscopic Partial
Meniscectomy
(N = 161)

14.7 (12.0 to 17.5)

WOMAC physical-function score — mean (95% CI)

6 Months

Outcome

Table 2. Primary and Secondary Outcomes of the Trial.*
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A
50

WOMAC Physical-Function Score

Figure 2. Scores on the WOMAC Physical-Function
Scale and KOOS Pain Scale over the 12-Month Followup Period.
Panel A shows the scores on the physical-function scale
of the Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC), and Panel B shows
the scores on the pain scale of the Knee Injury and
Osteoarthritis Outcome Scale (KOOS); scores on both
scales range from 0 to 100, with higher scores indicating
more severe symptoms. I bars indicate 95% confidence
intervals. Panel C shows WOMAC physical-function
scores in the APM group and in the PT group according to crossover status. The asterisk indicates that nine
patients assigned to APM did not undergo surgery.

45
40
35
30
25
20

PT

15
APM

10
0

Baseline

3

6

9

12

Months

n engl j med 368;18

No. at Risk
APM
PT

159
167

154
155

147
153

140
144

B
50
45

KOOS Pain Score

40
35
30
PT

25
20

APM

15
10
0

Baseline

3

6

9

12

Months
No. at Risk
APM
PT

160
167

155
154

148
153

142
145

C
APM
PT, no crossover
PT, crossover <3 mo
PT, crossover 3–6 mo
PT, crossover >6 mo

50

WOMAC Physical-Function Score

between groups (difference, 3.4 points; 95% CI,
−0.04 to 6.8). In the intention-to-treat analysis of
the KOOS pain score, the mean decreases (i.e.,
improvements) from baseline to 6 months were
24.2 points in patients assigned to arthroscopic
partial meniscectomy versus 21.3 points in those
assigned to physical therapy alone (betweengroup difference, 2.9 points; 95% CI, −1.2 to 7.0)
(Table 2 and Fig. 2B). In intention-to-treat analyses of 12-month outcomes adjusted for study site,
the two groups had similar changes from baseline in the WOMAC physical-function and KOOS
pain scores (Table 2).
Among 330 active participants in the study, by
6 months of follow-up, 51 patients assigned to
physical therapy alone (30.2%) had undergone
arthroscopic partial meniscectomy, whereas 9 patients assigned to surgery (5.6%) had not undergone the procedure. An additional 8 active patients in the study (4.7%) who were assigned to
the physical-therapy group crossed over to arthroscopic partial meniscectomy between 6 and
12 months. At 6 months, 67.1% of the patients
assigned to arthroscopic partial meniscectomy
had an improvement of at least 8 points in the
WOMAC physical-function score and had not
crossed over to the other study treatment, as
compared with 43.8% of patients assigned to the
physical-therapy group (P = 0.001). Patients in
the physical-therapy group who crossed over and
underwent arthroscopic partial meniscectomy
during the first 6 months had WOMAC physicalfunction scores at 12 months that were similar
to those of patients assigned to the arthroscopicpartial-meniscectomy group (Fig. 2C). The proportion of patients who crossed over from physical therapy to arthroscopic partial meniscectomy
ranged from 0.0 to 59.5% across study centers. In
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Table 3. Adverse Events at 12 Months in All Patients Assigned to Treatment.
Arthroscopic Partial
Meniscectomy
(N = 174)

Event

Physical Therapy
(N = 177)

number of patients
Serious adverse events
Cardiovascular
Pulmonary embolism (fatal)

1

0

Acute myocardial infarction

1

0

Sudden death

0

1

Stroke

0

1

Hypoxemia

1

0

Total

3

2

Pain from fall or other trauma

2

4

Tendonitis

3

0

Knee bursitis

0

1

Rupture of Baker’s cyst

1

0

Knee pain

1

1

2

4

2

0

Syncope

1

0

Atrial fibrillation

0

1

Skin

2

1

Other

1

1

15

13

Nonserious adverse events
Musculoskeletal

Pain in the back, hip, or foot
Cardiovascular
Deep-vein thrombosis

Total

general, the patients assigned to receive physical
therapy alone who crossed over to surgery did not
have substantial improvement in functional status
during the period from randomization until the
time of crossover (Fig. 2C).
In the physical-therapy group, patients were
scheduled for an average of 9.3 physical-therapy
visits and attended an average of 8.4 visits (90.6%).
In the arthroscopic-partial-meniscectomy group,
patients were scheduled for an average of 7.4
visits and attended 6.9 visits (92.9%). In the
physical-therapy group, 21 patients (12.4%) received intraarticular glucocorticoid injections, as
did 9 patients (5.6%) in the arthroscopic-partialmeniscectomy group.
The between-group difference in functional
improvement from baseline to 6 months did not
differ significantly according to the Kellgren–
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Lawrence grade of radiographic severity (P = 0.13
for interaction) (Table 3 in the Supplementary
Appendix).
Adverse Events

There were no significant between-group dif
ferences in the frequencies of overall or specific
adverse events. Over the 12-month period of followup, serious adverse events occurred in 3 participants assigned to arthroscopic partial meniscectomy and 2 participants assigned to physical
therapy alone (including one death in each group);
adverse events rated as mild or moderate in severity occurred in 15 participants in the arthroscopicpartial-meniscectomy group and 13 participants
in the physical-therapy group (Table 3). Total
knee replacement (coded not as an adverse event
but rather as an indication for discontinuation
from the study) was performed in 5 participants
assigned to arthroscopic partial meniscectomy
and 3 participants assigned to physical therapy
alone (Fig. 1).

Discussion
In this seven-center randomized, controlled trial
involving symptomatic patients 45 years of age or
older with a meniscal tear and imaging evidence
of mild-to-moderate knee osteoarthritis, there
were no significant differences in the magnitude
of improvement in functional status and pain after 6 and 12 months between patients assigned to
arthroscopic partial meniscectomy with postoperative physical therapy and patients assigned to a
standardized physical-therapy regimen. These results were achieved with a 30% rate of crossover
to arthroscopic partial meniscectomy at 6 months.
At 12 months, among 169 participants (not all of
whom provided data at the 1-year evaluation), the
rate of crossover to surgery was 35%.
In a prior small, single-center, randomized,
controlled trial comparing arthroscopic partial
meniscectomy with standardized physical therapy for symptomatic patients with a meniscal tear
and knee osteoarthritis, the two groups had similar functional outcomes at 6 months, and the
similarity between the groups persisted through
5 years of follow-up.8,9 To our knowledge, this is
the first large, multicenter, randomized, controlled
trial to examine the efficacy of arthroscopic partial meniscectomy as compared with a standardized physical-therapy regimen.
nejm.org
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Surgical randomized, controlled trials present
methodologic challenges, including crossover from
one group to the other.24,25 To account for crossovers, we defined an additional outcome a priori
in which patients were deemed to have a successful treatment response if they had improvement
of at least 8 points on the WOMAC physicalfunction scale (a clinically important difference)
and they did not cross over from their assigned
treatment. A total of 67% of patients assigned to
arthroscopic partial meniscectomy met this threshold for success, as compared with 44% of patients
treated with physical therapy alone. We acknowledge, however, that because the treatment assignments were not blinded, and because crossover
could not occur in the arthroscopic-partial-meniscectomy group once the surgery had been performed, this secondary analysis was vulnerable
to bias.
Several limitations of the study warrant discussion. First, because we enrolled only 26% of eligible patients, our findings must be generalized
cautiously. The most frequent reason that patients
declined enrollment was a strong preference for
one treatment or the other. Since patients’ preferences may be associated with treatment outcome,
our trial may be vulnerable to selection bias. Participating surgeons may not have referred potentially eligible patients because they were uncomfortable randomly assigning these patients to
treatment; this form of selective enrollment may
also create bias.26 Second, because the trial was
conducted in academic referral centers, the findings should be generalized carefully to community settings. Third, we did not formally assess
the fidelity of the physical therapists or surgeons
to the standard intervention protocols. Finally,
our study was not blinded, since our investigative group did not consider a sham comparison
group feasible.
These limitations notwithstanding, the results
of our trial may help guide management in the
care of patients with knee symptoms, a meniscal
tear, and imaging evidence of osteoarthritis. Our
findings suggest that both arthroscopic partial
meniscectomy and referral to physical therapy —
with an opportunity to consider arthroscopic partial meniscectomy if substantial improvements are
not achieved — are likely to result in considerable
improvement in functional status and knee pain
over a 6-to-12-month period. Given that improvements in functional status and pain at 6 months
n engl j med 368;18

did not differ significantly between patients assigned to arthroscopic partial meniscectomy and
those assigned to physical therapy alone and that
70% of the patients in the physical-therapy group
did not undergo surgery, these data provide considerable reassurance regarding an initial nonoperative strategy. It is uncertain whether patients
who undergo arthroscopic partial meniscectomy
are at greater risk for progression of underlying
osteoarthritis than patients treated nonoperatively.27-30 Longitudinal assessment of imaging studies
in our trial is planned to address this question.
In summary, symptomatic patients with a
meniscal tear and imaging evidence of mild-tomoderate osteoarthritis who were randomly assigned to arthroscopic partial meniscectomy with
postoperative physical therapy had improvements
in functional status and pain at 6 months that
did not differ significantly from the improvements
in patients randomly assigned to a standardized
physical-therapy regimen alone. However, 30% of
patients assigned to the physical-therapy group
crossed over to surgery in the first 6 months.
These findings should help inform decision making by patients and their physicians.
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